PINK1 pathway to Parkinson’s: 20 years on

Event Notes:

Join us as we commemorate 20 years of PTEN-induced kinase 1’s (PINK1) significance in Parkinson’s disease (PD) research. Disruption of mitochondrial quality control pathways has emerged as a central mechanism of PD and is exploited by pharmaceutical companies for novel therapeutics. Discover new insights into PINK1, Parkin, and mitophagy components, as we shed light on neurobiology and immunology. Delve into translational aspects, from cellular models to clinical trials, and connect with experts across academia and industry.

Showcase your research through abstract submissions for oral and poster presentations, with opportunities for flash talks. This conference welcomes early-career researchers, providing networking opportunities and a platform to present your work. This event is ideal for those working in cell biology, biochemistry, neuroscience, pharmaceuticals, biotechnology, and clinical neurology.

Scientific Programme Coordinators:

Helene Plun Favreau, UCL Institute of Neurology
Miratul Muqit, University of Dundee
Nicholas Wood, UCL Institute of Neurology
Invited Speakers:

Olga Corti, ICM, Sorbonne University
Sonia Gandhi, The Francis Crick Institute, UK
Wade Harper, Harvard University
Jim Hurley, UC Berkeley
Mike Lazarou, WEHI
Paul Thompson, Mission Therapeutics
Jean-Francois Trempe, McGill University
Sylvie Urbé, University of Liverpool
Enza Maria Valente, University of Pavia
Helen Walden, University of Glasgow
Alex Whitworth, University of Cambridge
Richard Youle, National Institutes of Health